Systemic and targeted activation of Nrf2 reverses doxorubicin-induced cognitive impairments and sensorimotor deficits in mice
Anand Kumar Singh, David Ruiz, Mohd Sami Ur Rasheed, Thomas D. Avery, Dion J. L. Turner, Andrew David Abell, Peter M. Grace
This study shows that Nrf2 activators reverse doxorubicin-induced cognitive and motor impairments and brain structural changes in mice.
bioRxiv · Jun 10, 2024 · PreprintNeuroscience